Back to Journals » Drug Design, Development and Therapy » Volume 16

Inhibition of JNK Phosphorylation by Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury [Corrigendum]

Authors Xiao Z, Xu F, Zhu X, Bai B, Guo L, Liang G, Shan X, Zhang Y, Zhao Y, Zhang B 

Received 6 January 2022

Accepted for publication 6 January 2022

Published 19 January 2022 Volume 2022:16 Pages 249—250

DOI https://doi.org/10.2147/DDDT.S357280



Xiao Z, Xu F, Zhu X, et al. Drug Des Devel Ther. 2019;1:4161–4171.

The authors have advised Funding section on page 4170 should be:

Funding

This study was supported by the Natural Science Funding of China (21572166 to Y.Z., and 81770850 to X.S.), Zhejiang Provincial Natural Science Funding (LY19H310001 to B.Z., and LY17H050007 to X.S.), and Project for Science and Technology of Huzhou (2015GY08 to L.G.).

Read the original article

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.